The Karma system is currently undergoing maintenance (Monday, January 29, 2018).
The maintenance period has been extended to 8PM EST.
Karma Credits will not be available for redeeming during maintenance.
Emerging Technologies, Medical Devices, Apps, Sensors, and Informatics to Help People with Diabetes.
JMIR Diabetes (JD) is a new sister journal of JMIR (the leading open-access journal in health informatics (Impact Factor 2017: 4.671), focusing on technologies, medical devices, apps, engineering, informatics and patient education for diabetes prevention, self-management, care, and cure, to help people with diabetes. As open access journal we are read by clinicians and patients alike and have (as all JMIR journals) a focus on readable and applied science reporting the design and evaluation of health innovations and emerging technologies, as well as on diabetes epidemiology. We publish original research, viewpoints, and reviews (both literature reviews and medical device/technology/app reviews) covering for example wearable devices and trackers, mobile apps, glucose monitoring (including emerging technologies such as Google contact lens), medical devices for insulin and metabolic peptide delivery, closed loop systems and artificial pancreas, telemedicine, web-based diabetes education and elearning, innovations for patient self-management and "quantified self", diabetes-specific EHR improvements, clinical or consumer-focused software, diabetes epidemiology and surveillance, crowdsourcing and quantified self-based research data, new sensors and actuators to be applied to diabetes.
Right click to copy or hit: ctrl+c (cmd+c on mac)
This manuscript needs more reviewersPeer-Review Me
Background: Diabetes is increasing in prevalence and complexity in the care home setting, affecting up to a quarter of care home residents. Health outcomes for these residents are impacted by manageme...
Background: Diabetes is increasing in prevalence and complexity in the care home setting, affecting up to a quarter of care home residents. Health outcomes for these residents are impacted by management of the disease, healthcare professionals’ decision-making skills within the care home setting, and access to specialist services. The use of technology has the potential to recognise opportunities for early intervention enabling efficient responsive care, and taking a fundamental role in linking the care home community to wider multi-disciplinary teams for support. Objective: To identify evidence that explores factors relevant to the use of technology in and around the care home setting for the management of diabetes. Methods: Databases searched using a structured pre-specified approach included: PUBMED, CINAHL, OVID Nursing database, SCOPUS, MEDLINE, Cochrane Library and the KINGS FUND from 2012- 2017, handsearching was undertaken additionally for any grey literature. PRISMA P was used as protocol with ROBIS to assess the risk of bias across studies. Studies had to include interventions that combined technology to or from the care home setting to support residents living with diabetes. Results: The combined search strategy identified a total of 493 electronic records.171 were screened for eligibility, 66 full papers were accessed and 13 have been included in this study. Interpretive synthesis has identified different strands of research evidence in what and how technology is currently being used in and around care homes to enhance diabetes management. New initiatives and implementations of technology and emerging models of care that included the use of technology have also been included. Conclusions: By triangulating the perspectives of healthcare professionals, practitioners, specialists and members of the care home community, the authors anticipate that this review will represent an up to date, evidenced-based overview of the potential for using technology within the care home setting for diabetes management as well as stimulate research in this area. Clinical Trial: N/A
Background: Widespread metaphors contribute to the public’s understanding of health. Prior work has characterized the metaphors used to describe cancer and AIDS. Less is known about the metaphors ch...
Background: Widespread metaphors contribute to the public’s understanding of health. Prior work has characterized the metaphors used to describe cancer and AIDS. Less is known about the metaphors characterizing cardiovascular disease. Objective: To characterize the metaphors that Twitter users employ in discussing hypertension and diabetes. Methods: We filtered approximately 10 billion tweets for keywords related to diabetes and hypertension. A random subset of 5000 tweets were coded for presence of metaphor and the type of metaphor employed. Results: We identified 797 (16%) tweets about hypertension or diabetes that employed metaphors. When discussing the development of heart disease, Twitter users described the disease as a journey (n=202), as transmittable (n=116), as an object (n=49) or person-like (n=14). In discussing the experience of disease, Twitter users employed war metaphors (n=101). Other users described the challenge to control their disease (n=43), the disease as an agent (n=58), or their bodies as machines (n=205). Conclusions: Metaphors are used frequently by Twitter users in their discussion of hypertension and diabetes. These metaphors can help to guide communication between patients and providers to improve public health.
Background: Health information technology tools (e.g., patient portals) have the potential to promote engagement, improve patient-provider communication, and enhance clinical outcomes in the managemen...
Background: Health information technology tools (e.g., patient portals) have the potential to promote engagement, improve patient-provider communication, and enhance clinical outcomes in the management of chronic disorders such as diabetes mellitus (DM). Objective: In this paper, we report the findings of a literature review of studies reporting on patient portal use by individuals with type 1 or type 2 DM. We examined the association of the patient portal use on DM-related outcomes and identified opportunities for further improvement in DM management. Methods: Electronic literature searches were conducted through PubMed and PsycINFO databases. The keywords used were “patient portal*,” “web portal,” “personal health record,” and “diabetes.” Inclusion criteria included: 1) published in the past 10 years, 2) used English language, 3) restricted to age ≥ 18 years, and 4) available in full text. Results: This review included 6 randomized controlled trials, 16 observational, 4 qualitative and 4 mixed methods studies. The results of these studies revealed that 29%–46% of patients with DM have registered for a portal account with 27%–76% of these patients actually using the portal at least once during the study period. Portal use was associated with the following factors: personal traits (e.g., socio-demographics, clinical characteristics, health literacy), technology (e.g., functionality, usability), and provider engagement. Inconsistent findings were observed regarding the association of patient portal use on DM-related clinical and psychological outcomes. Conclusions: Barriers to use of the patient portal were identified among patients and providers. Future investigations into strategies that both engage physicians and patients in use of a patient portal to improve patient outcomes are needed.